Keyword Index
Browse for an article via relevant keywords across our entire electronic archive
Search results for: U
Results 1 - 10 of 73 shown below
u-PAR
H Allgayer, H Wang, S Shirasawa, T Sasazuki and D Boyd
Targeted disruption of the K-Ras oncogene in an invasive colon cancer cell line down-regulates urokinase receptor expression and plasminogen-dependent proteolysis
doi:10.1038/sj.bjc.6690616
U1 small nuclear RNA
K Kato, Y Hitomi, K Imamura and H Esumi
Hyperstable U1snRNA complementary to the K-ras transcripts induces cell death in pancreatic cancer cells
doi:10.1038/sj.bjc.6600563
Abstract | Full article | PDF
UbcH10
P Pallante, M T Berlingieri, G Troncone, M Kruhoffer, T F Orntoft, G Viglietto, A Caleo, I Migliaccio, M Decaussin-Petrucci, M Santoro, L Palombini and A Fusco
UbcH10 overexpression may represent a marker of anaplastic thyroid carcinomas
advance online publication, 2005-08-02 00:00:00.000;
doi:10.1038/sj.bjc.6602721
Abstract | Full article | PDF
ubiquitin
N Carbó, J López-Soriano, P Costelli, S Busquets, B Alvarez, F M Baccino, L S Quinn, F J López-Soriano and J M Argilés
Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats
doi:10.1054/bjoc.2000.1299
ubiquitin-proteasome proteolysis
M C C Gomes-Marcondes, H J Smith, J C Cooper and M J Tisdale
Development of an in-vitro model system to investigate the mechanism of muscle protein catabolism induced by proteolysis-inducing factor
doi:10.1038/sj.bjc.6600236
Abstract | Full article | PDF
-
J Khal, S M Wyke, S T Russell, A V Hine and M J Tisdale
Expression of the ubiquitin-proteasome pathway and muscle loss in experimental cancer cachexia
advance online publication, 2005-09-06 00:00:00.000;
doi:10.1038/sj.bjc.6602780
Abstract | Full article | PDF
-
M J Lorite, H J Smith, J A Arnold, A Morris, M G Thompson and M J Tisdale
Activation of ATP-ubiquitin-dependent proteolysis in skeletal muscle in vivo and murine myoblasts in vitro by a proteolysis-inducing factor (PIF)
doi:10.1054/bjoc.2001.1879
UCN-01
L C Playle, D J Hicks, D Qualtrough and C Paraskeva
Abrogation of the radiation-induced G2 checkpoint by the staurosporine derivative UCN-01 is associated with radiosensitisation in a subset of colorectal tumour cell lines
doi:10.1038/sj.bjc.6600492
Abstract | Full article | PDF
-
W-S Yeow, M F Ziauddin, J B Maxhimer, S Shamimi-Noori, A Baras, A Chua, D S Schrump and D M Nguyen
Potentiation of the anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the kinase inhibitor Staurosporine or its clinically relevant analogue UCN-01
doi:10.1038/sj.bjc.6603132
Abstract | Full article | PDF
UFT
T Seto, K Yoh, H Asoh, H Yamamoto, H Semba and Y Ichinose
A phase I study of combination chemotherapy with gemcitabine and oral UFT for advanced non-small cell lung cancer
doi:10.1038/sj.bjc.6600337
Abstract | Full article | PDF
-
C J Twelves and J Cassidy
Which endpoints should we use in evaluating the use of novel fluoropyrimidine regimens in colorectal cancer?
doi:10.1038/sj.bjc.6600341
Abstract | Full article | PDF
-
S Ohwada, T Ikeya, T Yokomori, T Kusaba, T Roppongi, T Takahashi, S Nakamura, S Kakinuma, S Iwazaki, H Ishikawa, S Kawate, T Nakajima and Y Morishita
Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer: a randomised controlled study
doi:10.1038/sj.bjc.6601619
Abstract | Full article | PDF
-
J Feliu, J M Vicent, C García-Girón, M Constela, E Fonseca, J Aparicio, M Lomas, L Antón-Aparicio, F J Dorta and M Gonzalez-Baron
Phase II study of UFT and oxaliplatin in first-line treatment of advanced colorectal cancer
advance online publication, 2004-10-26 00:00:00.000;
doi:10.1038/sj.bjc.6602217
Abstract | Full article | PDF
-
S C Oh, K H Park, I K Choi, S Y Yoon, S J Kim, J H Seo, C W Choi, B S Kim, S W Shin, J S Kim and Y H Kim
Docetaxel (Taxotere), cisplatin, UFT, and leucovorin combination chemotherapy in advanced gastric cancer
advance online publication, 2005-02-22 00:00:00.000;
doi:10.1038/sj.bjc.6602446
Abstract | Full article | PDF
-
Y Ichinose, T Seto, H Semba, K Itoh, Y Inoue, F Tanaka, J Araki, M Tamanoi, H Yamamoto and N Iwamoto
UFT plus gemcitabine combination chemotherapy in patients with advanced non-small-cell lung cancer: a multi-institutional phase II trial
advance online publication, 2005-09-20 00:00:00.000;
doi:10.1038/sj.bjc.6602781
Abstract | Full article | PDF
-
Y Chao, C P Li, T Y Chao, W C Su, R K Hsieh, M F Wu, K H Yeh, W Y Kao, L T Chen and A L Cheng
An open, multi-centre, phase II clinical trial to evaluate the efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancer
advance online publication, 2006-06-27 00:00:00.000;
doi:10.1038/sj.bjc.6603225
Abstract | Full article | PDF
-
K Nakagawa, H Tada, A Akashi, T Yasumitsu, K Iuchi, T Taki and K Kodama
Randomised study of adjuvant chemotherapy for completely resected p-stage I–IIIA non-small cell lung cancer
advance online publication, 2006-09-12 00:00:00.000;
doi:10.1038/sj.bjc.6603336
Abstract | Full article | PDF
-
E Bajetta, M Di Bartolomeo, R Buzzoni, L Mariani, N Zilembo, E Ferrario, S Lo Vullo, E Aitini, L Isa, C Barone, S Jacobelli, E Recaldin, G Pinotti and A Iop
Uracil/ftorafur/leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: results of randomised phase II study
advance online publication, 2007-01-23 00:00:00.000;
doi:10.1038/sj.bjc.6603493
Abstract | Full article | PDF
-
H Y Sheikh, J W Valle, K Palmer, A Sjursen, O Craven, G Wilson, R Swindell and M P Saunders
Concurrent irinotecan, oxaliplatin and UFT in first-line treatment of metastatic colorectal cancer: a Phase I study
doi:10.1038/sj.bjc.6603521
Abstract | Full article | PDF
-
J Sakamoto, C Hamada, S Yoshida, S Kodaira, M Yasutomi, T Kato, K Oba, H Nakazato, S Saji and Y Ohashi
An individual patient data meta-analysis of adjuvant therapy with uracil–tegafur (UFT) in patients with curatively resected rectal cancer
advance online publication, 2007-03-20 00:00:00.000;
doi:10.1038/sj.bjc.6603686
Abstract | Full article | PDF
-
J-P Delord, J Bennouna, P Artru, H Perrier, F Husseini, F Desseigne, E François, R Faroux, D Smith, P Piedbois, H Naman, J Y Douillard and R Bugat
Phase II study of UFT with leucovorin and irinotecan (TEGAFIRI): first-line therapy for metastatic colorectal cancer
advance online publication, 2007-07-17 00:00:00.000;
doi:10.1038/sj.bjc.6603889
Abstract | Full article | PDF
-
F Tanaka, Y Otake, K Yanagihara, T Yamada, R Miyahara, Y Kawano, M Li, K Inui and H Wada
Apoptosis and p53 status predict the efficacy of postoperative administration of UFT in non-small cell lung cancer
doi:10.1054/bjoc.2000.1579
Uganda
R Newton, J Ziegler, C Ateenyi-Agaba, L Bousarghin, D Casabonne, V Beral, E Mbidde, L Carpenter, G Reeves, D M Parkin, H Wabinga, S Mbulaiteye, H Jaffe, D Bourboulia, C Boshoff, A Touzé and P Coursaget
The epidemiology of conjunctival squamous cell carcinoma in Uganda
doi:10.1038/sj.bjc.6600451
Abstract | Full article | PDF
-
R Newton, J Ziegler, D Bourboulia, D Casabonne, V Beral, E Mbidde, L Carpenter, D M Parkin, H Wabinga, S Mbulaiteye, H Jaffe, R Weiss and C Boshoff
Infection with Kaposi's sarcoma-associated herpesvirus (KSHV) and human immunodeficiency virus (HIV) in relation to the risk and clinical presentation of Kaposi's sarcoma in Uganda
doi:10.1038/sj.bjc.6601113
Abstract | Full article | PDF
-
A Gondos, H Brenner, H Wabinga and D M Parkin
Cancer survival in Kampala, Uganda
advance online publication, 2005-04-12 00:00:00.000;
doi:10.1038/sj.bjc.6602540
Abstract | Full article | PDF
-
M L Tornesello, M L Duraturo, K M Waddell, B Biryahwaho, R Downing, S Balinandi, S B Lucas, L Buonaguro and F M Buonaguro
Evaluating the role of human papillomaviruses in conjunctival neoplasia
advance online publication, 2006-01-10 00:00:00.000;
doi:10.1038/sj.bjc.6602921
Abstract | Full article | PDF
UK Europe
R Doll and J Boreham
Recent trends in cancer mortality in the UK
advance online publication, 2005-03-22 00:00:00.000;
doi:10.1038/sj.bjc.6602450
Abstract | Full article | PDF
UKCCSG 9002 protocol
A Atra, J D Imeson, R Hobson, M Gerrard, I M Hann, O B Eden, R L Carter and C R Pinkerton
Improved outcome in children with advanced stage B-cell non-Hodgkin's lymphoma (B-NHL): results of the United Kingdom Children Cancer Study Group (UKCCSG) 9002 protocol
doi:10.1054/bjoc.1999.1083